Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0001510281-24-000322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-06-10 | 2024-06-06+ | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.78 | +13.4K | 3.39M | +0.4% | +$184.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-07 | P | A | 3,763 | $13.72 | 3,393,469 | I - | — | — | |
| 2 | Common | Common Stock | 2024-06-06 | P | A | 9,598 | $13.80 | 3,389,706 | I - | — | — |